In our study, the high frequency of SETD2 and SMAD4 mutations in advanced CRC and the poor survival of patients with SETD2 and SMAD4 mutations confirmed the important roles of SETD2 and SMAD4 in CRC. Here, SMAD4 is linked to colorectal carcinoma.